ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
38.18
-0.13%
US Tech 100
19,440.00
-0.71%
S&P 500
5,740.52
-0.08%
US Dollar vs CAD
1.35197
0.31%
Bitcoin
65,788.01
0.92%
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Organogenesis Holdings Inc (ORGO)

  7. Organogenesis Holdings Inc (ORGO) News

ORGO

Organogenesis (ORGO)

Organogenesis Holdings Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:ORGO
DateTimeSourceHeadlineSymbolCompany
09/04/20243:05PMGlobeNewswire Inc.Organogenesis Holdings Inc. to Participate in Upcoming Investor Conferences in SeptemberNASDAQ:ORGOOrganogenesis Holdings Inc
08/15/202411:15PMEdgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:ORGOOrganogenesis Holdings Inc
08/08/20243:44PMEdgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:ORGOOrganogenesis Holdings Inc
08/08/20243:15PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:ORGOOrganogenesis Holdings Inc
08/08/20243:05PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:ORGOOrganogenesis Holdings Inc
08/08/20243:05PMGlobeNewswire Inc.Organogenesis Holdings Inc. Reports Second Quarter 2024 Financial ResultsNASDAQ:ORGOOrganogenesis Holdings Inc
08/08/20243:04PMGlobeNewswire Inc.Organogenesis Shares ReNu® Program UpdateNASDAQ:ORGOOrganogenesis Holdings Inc
07/18/20244:03PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ORGOOrganogenesis Holdings Inc
07/15/20243:05PMGlobeNewswire Inc.Organogenesis Holdings Inc. to Report Second Quarter of Fiscal Year 2024 Financial Results on August 8, 2024NASDAQ:ORGOOrganogenesis Holdings Inc
06/06/20243:05PMGlobeNewswire Inc.Organogenesis Holdings Inc. to Participate in the Truist Securities MedTech ConferenceNASDAQ:ORGOOrganogenesis Holdings Inc
05/09/20243:25PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:ORGOOrganogenesis Holdings Inc
05/09/20243:05PMGlobeNewswire Inc.Organogenesis Holdings Inc. Reports First Quarter 2024 Financial ResultsNASDAQ:ORGOOrganogenesis Holdings Inc
05/02/20246:00AMGlobeNewswire Inc.Organogenesis Achieves Primary Endpoint in Phase 3 Clinical Trial of ReNu® for Knee OsteoarthritisNASDAQ:ORGOOrganogenesis Holdings Inc
04/16/20246:30AMGlobeNewswire Inc.Organogenesis Holdings Inc. to Report First Quarter of Fiscal Year 2024 Financial Results on May 9, 2024NASDAQ:ORGOOrganogenesis Holdings Inc
04/03/20246:30AMGlobeNewswire Inc.Organogenesis Announces Favorable Court Ruling Dismissing Securities Fraud CaseNASDAQ:ORGOOrganogenesis Holdings Inc
02/29/20243:31PMEdgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:ORGOOrganogenesis Holdings Inc
02/29/20243:05PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:ORGOOrganogenesis Holdings Inc
02/29/20243:05PMGlobeNewswire Inc.Organogenesis Holdings Inc. Reports Fourth Quarter 2023 and Fiscal Year 2023 Financial Results; Introduces Fiscal Year 2024 GuidanceNASDAQ:ORGOOrganogenesis Holdings Inc
02/23/20244:24PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ORGOOrganogenesis Holdings Inc
02/23/20244:24PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ORGOOrganogenesis Holdings Inc
02/23/20244:23PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ORGOOrganogenesis Holdings Inc
02/23/20244:23PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ORGOOrganogenesis Holdings Inc
02/23/20244:23PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ORGOOrganogenesis Holdings Inc
02/23/20244:22PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ORGOOrganogenesis Holdings Inc
02/23/20244:21PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ORGOOrganogenesis Holdings Inc
02/23/20244:21PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ORGOOrganogenesis Holdings Inc
02/23/20244:20PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ORGOOrganogenesis Holdings Inc
02/20/20247:19PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ORGOOrganogenesis Holdings Inc
02/20/20247:19PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ORGOOrganogenesis Holdings Inc
02/20/20247:18PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ORGOOrganogenesis Holdings Inc
 Showing the most relevant articles for your search:NASDAQ:ORGO

Your Recent History

LSE
94QA
Comw.bk.a. 31
LSE
55NB
Nordic 46
ASX
MTI
Montec International
LSE
FF24
Citi Fun 27
HITB
REVBTC
Revain
COIN
POPEETH
Proof Of Pepe
TSXV
CTP.P
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Canada
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved